Increasing evidences showed that TREM2 exhibited some protective effects, including anti-inflammation, autophagy inhibition and enhanced phagocytosis in neurodegenerative diseases, such as AD, Parkinson's disease (PD), and epilepsy [38]. Here, TREM2 is linked to neurodegenerative disease.